FDA Import Refusal AEK-8210662-4/11/1 — ZISKA PHARMA
The FDA refused shipment AEK-8210662-4/11/1 from ZISKA PHARMA (Bangladesh) on Feb 27, 2025. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charges: 118,3280,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Feb 27, 2025
- Country
- Bangladesh
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 118,3280,75